Back to funds

First Turn Management, LLC

Updated 6 days ago

Managed by First Turn Management, Llc • Latest filing Q3 2026

Portfolio value
$753M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$875.2M
Q1 2026$895.1M
Q2 2026$934.7M
Q3 2026$753M

Top holdings

38 positions as of Q3 2026

View filing
E

ENLIVEN THERAPEUTICS INC

Value
$43.9M
Shares
958.7K
% Port
5.84%
G

GUARDANT HEALTH INC

Value
$39.1M
Shares
219.3K
% Port
5.19%
A

ABIVAX SA

Value
$38.1M
Shares
384.6K
% Port
5.06%
R

ROIVANT SCIENCES LTD

Value
$36M
Shares
985.6K
% Port
4.79%
U

UNITED THERAPEUTICS CORP DEL

Value
$32.5M
Shares
60.1K
% Port
4.32%
V

VIRIDIAN THERAPEUTICS INC

Value
$31.4M
Shares
1.53M
% Port
4.17%
A

AXSOME THERAPEUTICS INC.

Value
$29.9M
Shares
162.4K
% Port
3.98%
I

INSMED INC

Value
$28M
Shares
245.7K
% Port
3.72%
C

CELCUITY INC

Value
$26.2M
Shares
329.1K
% Port
3.48%
C

CHARLES RIV LABS INTL INC

Value
$25.6M
Shares
86.8K
% Port
3.40%
C

CYTOKINETICS INC

Value
$23.6M
Shares
357.9K
% Port
3.13%
B

BRIDGEBIO PHARMA INC

Value
$23.3M
Shares
354.4K
% Port
3.10%
P

PRAXIS PRECISION MEDICINES I

Value
$23M
Shares
78.8K
% Port
3.05%
O

ORIC PHARMACEUTICALS INC

Value
$21.2M
Shares
1.57M
% Port
2.82%
R

REPLIGEN CORP

Value
$20.8M
Shares
108.4K
% Port
2.77%
T

TANGO THERAPEUTICS INC

Value
$19.1M
Shares
766.9K
% Port
2.54%
R

REVOLUTION MEDICINES INC

Value
$18.9M
Shares
92.3K
% Port
2.52%
I

INHIBRX BIOSCIENCES INC

Value
$17.2M
Shares
171.5K
% Port
2.28%
N

NEWAMSTERDAM PHARMA COMPANY

Value
$17.1M
Shares
702.4K
% Port
2.27%
M

VERADERMICS INC

Value
$16.6M
Shares
136.7K
% Port
2.20%

Explore